Outcome of Board Meeting attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunshield Chemicals reported strong FY26 results with revenue growing 20.5% to Rs. 44,091 lakhs from Rs. 36,579 lakhs in FY25. Profit after tax more than doubled to Rs. 2,960 lakhs from Rs. 1,457 lakhs, while EPS improved to Rs. 37.15 from Rs. 19.61. The Board recommended a final dividend of Rs. 3 per share (30% payout) and approved reappointment of Mr. Cyrus Poonevala as Independent Director for a second 5-year term. The company successfully completed a Rs. 12,990.40 lakh Rights Issue in October 2025, using proceeds to repay debts and for general corporate purposes. Statutory auditors CNK & Associates issued an Unmodified Opinion. Finance costs reduced significantly from Rs. 910 lakhs to Rs. 503 lakhs year-over-year.
The company delivered robust double-digit revenue growth and exceptional PAT growth, signaling strong operational performance. The dividend recommendation and clean audit opinion are positive signals for shareholders. Debt reduction through Rights Issue proceeds strengthens the balance sheet.